Goldman Sachs Downgrades Xylem (XYL) to Sell
Tweet Send to a FriendGet Alerts XYL Hot Sheet
Price: $28.91 +0.10%
Rating Summary:
8 Buy, 6 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 24 | New: 24
Rating Summary:
8 Buy, 6 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 24 | New: 24
Trade XYL Now!
Goldman Sachs downgraded Xylem (NYSE: XYL) from Neutral to Sell with a price target of $24.00 (from $29.00).
The firm cited concerns about prolonged weakness in European (30% of revs) and municipal water markets (35%). They also see less potential for M&A and said balance sheet optionality is below average.
For an analyst ratings summary and ratings history on Xylem click here. For more ratings news on Xylem click here.
Shares of Xylem closed at $24.29 yesterday, with a 52 week range of $22.67-$28.87.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The firm cited concerns about prolonged weakness in European (30% of revs) and municipal water markets (35%). They also see less potential for M&A and said balance sheet optionality is below average.
For an analyst ratings summary and ratings history on Xylem click here. For more ratings news on Xylem click here.
Shares of Xylem closed at $24.29 yesterday, with a 52 week range of $22.67-$28.87.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Sterne Agee Downgrades Beazer Homes (BZH) to Neutral
- Goldman Sachs Downgrades Equifax (EFX) to Neutral on Valuation
- Goldman Lowers PC Forecast and Warns of Aggressive Pricing at OEMs (HP) (DELL) (LXK) (QLGC)
Create E-mail Alert Related Categories
Downgrades, Hot DowngradesRelated Entities
Goldman SachsLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

